Explore more publications!

Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on April 13, 2026

Seacoast AI Uses Leverage’s Sovereign AI to Put Its Data to Work
Town of Millbury Partners with PlanetBids to Modernize and Streamline Procurement Processes
‘ImEx Cargo Expands Workforce Development Strategy to Power Digital Freight Infrastructure Through Plug-In Freight Ops™’
G6 Hospitality to Convene Its Largest Franchise Conference in Cancún
Boston Pads Database Surpasses 300,000 Units, Expanding Footprint Beyond Greater Boston
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
Dash Social Brings Canva Into Its Platform, Connecting Design, Data, and Publishing for Social Teams
AIM ImmunoTech Provides Routine Update on Annual Filings
CEA Industries Stapled Warrants to Begin Trading on Nasdaq Capital Market
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Datacentrex Reports Full Year 2025 Results; Achieves Positive Adjusted EBITDA in Transformational Year
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
Rezolve Ai to Host Investor Call: The $700M+ Case for Combining with Commerce.com
Varonis Announces Date of First Quarter 2026 Financial Results
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions